Contribution of KV7 channels to basal coronary flow and active response to ischemia

Hypertension

Volumn 62, Issue 6, 2013, Pages 1090-1097

  Khanamiri, Saereh ^a   Soltysinska, Ewa ^a   Jepps, Thomas A ^b   Bentzen, Bo H ^a   Chadha, Preet S ^b   Schmitt, Nicole ^a   Greenwood, Iain A ^b   Olesen, Søren Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adenosine; Coronary vessels; Hyperemia; Hypertension; Muscle; Smooth; Vascular; Vasodilation

Indexed keywords

ADENOSINE; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; POTASSIUM CHANNEL KCNQ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY PRESSURE; HEART MUSCLE ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD FLOW; BLOOD PRESSURE; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECTS; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION; VASODILATATION; WISTAR RAT; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HYPEREMIA; VASCULAR SMOOTH MUSCLE;

ADENOSINE; ANIMALS; BLOOD PRESSURE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; KCNQ POTASSIUM CHANNELS; MALE; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASODILATION;

ADENOSINE; CORONARY VESSELS; HYPEREMIA; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; VASODILATION;

EID: 84891593282     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01244     Document Type: Article

References (31)

1. Berwick ZC, Payne GA, Lynch B, Dick GM, Sturek M, Tune JD. Contribution of adenosine A (2A) and A (2B) receptors to ischemic coronary dilation: role of K (V) and K (ATP) channels. Microcirculation. 2010;17:600-607.
2. Dick GM, Bratz IN, Borbouse L, Payne GA, Dincer UD, Knudson JD, Rogers PA, Tune JD. Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation. Am J Physiol Heart Circ Physiol. 2008;294:H2371-H2381.
3. Chadha PS, Zunke F, Zhu HL, Davis AJ, Jepps TA, Olesen SP, Cole WC, Moffatt JD, Greenwood IA. Reduced KCNQ4-encoded voltagedependent potassium channel activity underlies impaired β-adrenoceptormediated relaxation of renal arteries in hypertension. Hypertension. 2012;59:877-884.
4. Chadha PS, Zunke F, Davis AJ, Jepps TA, Linders JT, Schwake M, Towart R, Greenwood IA. Pharmacological dissection of K (v) 7.1 channels in systemic and pulmonary arteries. Br J Pharmacol. 2012;166:1377-1387.
5. Gao Z, Zhang T, Wu M, Xiong Q, Sun H, Zhang Y, Zu L, Wang W, Li M. Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions. J Biol Chem. 2010;285:28322-28332.
6. Jepps TA, Chadha PS, Davis AJ, Harhun MI, Cockerill GW, Olesen SP, Hansen RS, Greenwood IA. Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Circulation. 2011;124:602-611.
7. Mackie AR, Byron KL. Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention. Mol Pharmacol. 2008;74:1171-1179.
8. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 1976;260:617-619.
9. Ng FL, Davis AJ, Jepps TA, Harhun MI, Yeung SY, Wan A, Reddy M, Melville D, Nardi A, Khong TK, Greenwood IA. Expression and function of the K+ channel KCNQ genes in human arteries. Br J Pharmacol. 2011;162:42-53.
10. Zavaritskaya O, Zhuravleva N, Schleifenbaum J, Gloe T, Devermann L, Kluge R, Mladenov M, Frey M, Gagov H, Fésüs G, Gollasch M, Schubert R. Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction. Hypertension. 2013;61:151-159.
11. Zhong XZ, Abd-Elrahman KS, Liao CH, El-Yazbi AF, Walsh EJ, Walsh MP, Cole WC. Stromatoxin-sensitive, heteromultimeric Kv2.1/Kv9.3 channels contribute to myogenic control of cerebral arterial diameter. J Physiol. 2010;588(Pt 22):4519-4537.
12. Hein TW, Wang W, Zoghi B, Muthuchamy M, Kuo L. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. J Mol Cell Cardiol. 2001;33:271-282.
13. Rubio R, Wiedmeier VT, Berne RM. Relationship between coronary flow and adenosine production and release. J Mol Cell Cardiol. 1974;6:561-566.
14. Chadha PS, Zunke F, Zhu HL, Davis AJ, Jepps TA, Olesen SP, Cole WC, Moffatt JD, Greenwood IA. Reduced KCNQ4-encoded voltagedependent potassium channel activity underlies impaired β-adrenoceptormediated relaxation of renal arteries in hypertension. Hypertension. 2012;59:877-884.
15. Ponnoth DS, Jamal Mustafa S. Adenosine receptors and vascular inflammation. Biochim Biophys Acta. 2011;1808:1429-1434.
16. Yeung SY, Lange W, Schwake M, Greenwood IA. Expression profile and characterisation of a truncated KCNQ5 splice variant. Biochem Biophys Res Commun. 2008;371:741-746.
17. Curnish RR, Berne RM, Rubio R. Effect of aminophylline on myocardial reactive hyperemia. Proc Soc Exp Biol Med. 1972;141:593-598.
18. McIntosh VJ, Lasley RD. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant? J Cardiovasc Pharmacol Ther. 2012;17:21-33.
19. Rochetaing A, Kreher P. Reactive hyperemia during early reperfusion as a determinant of improved functional recovery in ischemic preconditioned rat hearts. J Thorac Cardiovasc Surg. 2003;125:1516-1525.
20. Schleifenbaum J, Köhn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T, Crean CS, Luft FC, Huang Y, Schubert R, Gollasch M. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. J Hypertens. 2010;28:1875-1882.
21. Berne RM, Rubio R, Dobson JG Jr, Curnish RR. Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ Res. 1971;28(Suppl 1):115+.
22. Deussen A, Weichsel J, Pexa A. Features of adenosine metabolism of mouse heart. Purinergic Signal. 2006;2:663-668.
23. Hori M, Sato K, Sakata K, Ozaki H, Takano-Ohmuro H, Tsuchiya T, Sugi H, Kato I, Karaki H. Receptor agonists induce myosin phosphorylationdependent and phosphorylation-independent contractions in vascular smooth muscle. J Pharmacol Exp Ther. 1992;261:506-512.
24. Talukder MA, Morrison RR, Ledent C, Mustafa SJ. Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. J Cardiovasc Pharmacol. 2003;41:562-570.
25. Frøbert O, Haink G, Simonsen U, Gravholt CH, Levin M, Deussen A. Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation. J Physiol. 2006;570(Pt 2):375-384.
26. Kirkebøen KA, Aksnes G, Lande K, Ilebekk A. Role of adenosine for reactive hyperemia in normal and stunned porcine myocardium. Am J Physiol. 1992;263(4 Pt 2):H1119-H1127.
27. Tietjan CS, Tribble CG, Gidday JM, Phillips CL, Belardinelli L, Rubio R, Berne RM. Interstitial adenosine in guinea pig hearts: an index obtained by epicardial disks. Am J Physiol. 1990;259(5 Pt 2):H1471-H1476.
28. Zatta AJ, Headrick JP. Mediators of coronary reactive hyperaemia in isolated mouse heart. Br J Pharmacol. 2005;144:576-587.
29. Hodgson JM, Dib N, Kern MJ, Bach RG, Barrett RJ. Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. Am J Cardiol. 2007;99:1507-1512.
30. Morrison RR, Talukder MA, Ledent C, Mustafa SJ. Cardiac effects of adenosine in A (2A) receptor knockout hearts: uncovering A (2B) receptors. Am J Physiol Heart Circ Physiol. 2002;282:H437-H444.
31. Talukder MA, Morrison RR, Mustafa SJ. Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am J Physiol Heart Circ Physiol. 2002;282:H49-H57.